Garjae Dayan Lavien, MD | |
435 Phalen Blvd, Mail Stop 51103c, Saint Paul, MN 55130 | |
(651) 254-8500 | |
Not Available |
Full Name | Garjae Dayan Lavien |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 14 Years |
Location | 435 Phalen Blvd, Saint Paul, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659695310 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | 60491 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Regions Hospital | Saint paul, MN | Hospital |
Park Nicollet Methodist Hospital | Saint louis park, MN | Hospital |
Lakeview Memorial Hospital | Stillwater, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healthpartners Medical Group | 1759293954 | 1430 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.
The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.
The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.
› Verified 5 days ago
Entity Name | Park Nicollet Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780621904 PECOS PAC ID: 7911819438 Enrollment ID: O20031104000046 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.
The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.
The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.
› Verified 5 days ago
Entity Name | Group Health Plan Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.
The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.
The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Garjae Dayan Lavien, MD 8170 33rd Ave S, Ms 21110q, Bloomington, MN 55425-4516 Ph: (651) 254-8500 | Garjae Dayan Lavien, MD 435 Phalen Blvd, Mail Stop 51103c, Saint Paul, MN 55130 Ph: (651) 254-8500 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs being developed to treat inflammatory diseases, cancer and sexual dysfunction, today reported financial results for the three months ended March 31, 2015 and updates on its drug development programs.
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today initial results from the two-year Phase III ALLEGRO study, which demonstrated that relapsing-remitting multiple sclerosis (MS) patients treated with 0.6 mg daily oral laquinimod experienced a statistically significant reduction in annualized relapse rate compared to placebo. Additional clinical endpoints, including significant reduction in disability progression, as measured by Expanded Disability Severity Scale (EDSS), were also achieved.
The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.
The journal Accounts of Chemical Research, which has a profound impact on Chemistry and other related sciences, publishes on its current issue the article "Anion Transporters and Biological Systems", signed by Professor Ricardo Pérez Tomás, from the Department of Pathology and Experimental Therapy of the Faculty of Medicine at the University of Barcelona, Roberto Quesada, from the Department of Chemistry of the Sciences Faculty at the University of Burgos, and Philip A. Gale, from the University of Southampton, in the United Kingdom.
› Verified 5 days ago
Michael Howard Wipf, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 360 Sherman St, Suite 400, Saint Paul, MN 55102 Phone: 651-999-6800 Fax: 651-999-6910 | |
Dr. Joshua Lane Woelk, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1021 Bandana Blvd E Ste 100, Saint Paul, MN 55108 Phone: 651-241-9700 Fax: 651-241-9678 | |
Peter Donald Sershon, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 360 Sherman St, Suite 450, Saint Paul, MN 55102 Phone: 651-999-6800 Fax: 651-999-6810 | |
Michael Lee Pergament, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 360 Sherman St, Suite 400, Saint Paul, MN 55102 Phone: 651-999-6800 Fax: 651-999-6910 | |
Walter Paul Gleich, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 360 Sherman St, Suite 450, Saint Paul, MN 55102 Phone: 651-999-6800 Fax: 651-999-6808 | |
Robert David Fisher, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 360 Sherman St, Suite 450, Saint Paul, MN 55102 Phone: 651-999-6800 Fax: 651-999-6910 | |
Jesse Jacobs, Urology Medicare: Accepting Medicare Assignments Practice Location: 435 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-254-8500 |